经剖腹逆行开放肠系膜动脉支架置入术治疗急性和慢性肠系膜缺血的多中心研究
本研究回顾性分析2001至2013年间七个学术中心连续54例经剖腹逆行开放肠系膜动脉支架置入术(ROMS)患者的临床资料与结局。指征为急性肠系膜缺血44例(81%)和亚急性-on-慢性肠系膜缺血10例(19%)。急性肠系膜缺血早期死亡率为45%(20/44),亚急性-on-慢性肠系膜缺血为10%(1/10)(P = .04)。结论认为ROMS为需要剖腹探查或经皮支架置入失败/不适合的肠系膜齐平闭塞患者提供了替代方案,尽管技术成功率高,急性肠系膜缺血患者死亡率仍高。
要点
- ROMS适用于需剖腹探查的急性肠系膜缺血或经皮支架置入失败/不适合的肠系膜齐平闭塞患者。
- 急性肠系膜缺血早期死亡率为45%(20/44),亚急性-on-慢性肠系膜缺血为10%(1/10)(P = .04)。
- 2年一期通畅率和二期通畅率分别为76% ± 8%和90% ± 8%,无复发和再干预率分别为72% ± 8%和74% ± 8%。
核心结论
- ROMS为需要剖腹探查的急性肠系膜缺血患者以及经皮支架置入失败或不适合的肠系膜齐平闭塞患者提供了替代旁路或经皮支架置入的方案。
- 尽管技术成功率高,急性肠系膜缺血患者死亡率仍高。
- 通畅率及无复发和再干预率与经皮支架置入技术的结果相当。
研究设计与样本
- 回顾性多中心研究,纳入七个学术中心2001年至2013年连续54例经剖腹逆行开放肠系膜动脉支架置入术(ROMS)患者。
- ROMS通过剖腹术逆行进入目标肠系膜动脉,采用逆行或顺行方式置入支架。
- 终点包括早期(<30天)和晚期死亡率、并发症率、通畅率、无复发和无再干预率。
主要发现
- 共54例患者,男13例、女41例,平均年龄72 ± 11岁。
- 指征为急性肠系膜缺血44例(81%)和亚急性-on-慢性肠系膜缺血伴肠系膜齐平闭塞10例(19%)。
- 共置入56根目标肠系膜血管支架,包括52根肠系膜上动脉和4处腹腔干病变,平均治疗长度42 ± 26 mm。
- 所有患者均采用逆行肠系膜入路,其中16例同时需要顺行肱动脉入路。
- 逆行穿刺点一期闭合34例,补片血管成形术闭合17例,手动压迫1例。
临床怎么用
- 作者认为ROMS可为需要剖腹探查的急性肠系膜缺血患者以及经皮支架置入失败或不适合的肠系膜齐平闭塞患者提供替代旁路或经皮支架置入的选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Retrograde open mesenteric stenting (ROMS) through laparotomy was introduced as an alternative to surgical bypass in patients with acute mesenteric ischemia (AMI). The purpose of this study was to evaluate the indications and outcomes of ROMS for treatment of AMI and chronic mesenteric ischemia. METHODS: We reviewed the clinical data and outcomes of all consecutive patients treated by ROMS in seven academic centers from 2001 to 2013. ROMS was performed through laparotomy with retrograde access into the target mesenteric artery and stent placement using a retrograde or antegrade approach. End points were early (<30 days) and late mortality, morbidity, patency rates, and freedom from symptom recurrence and reintervention. RESULTS: There were 54 patients, 13 male and 41 female, with a mean age of 72 ± 11 years. Indications for ROMS were AMI in 44 patients (81%) and subacute-on-chronic mesenteric ischemia with flush mesenteric occlusion in 10 patients (19%). A total of 56 target mesenteric vessels were stented, including 52 superior mesenteric arteries and 4 celiac axis lesions, with a mean treatment length of 42 ± 26 mm. Retrograde mesenteric access was used in all patients, but 16 patients also required a simultaneous antegrade brachial approach. The retrograde puncture was closed primarily in 34 patients and with patch angioplasty in 17 patients; 1 patient had manual compression. Bowel resection was needed in 29 patients (66%) with AMI because of perforation or gangrene. Technical success was achieved in all (98%) except one patient for whom ROMS failed, who was treated by bypass. Early mortality was 45% (20/44) for AMI and 10% (1/10) for subacute-on-chronic mesenteric ischemia (P = .04). Early morbidity was 73% for AMI and 50% for subacute-on-chronic mesenteric ischemia (P = .27). Patient survival for the entire cohort was 43% ± 9% at 2 years. Primary patency and secondary patency at 2 years were 76% ± 8% and 90% ± 8%, respectively. Freedom from symptom recurrence and freedom from reinterventions were 72% ± 8% and 74% ± 8% at the same interval. CONCLUSIONS: ROMS offers an alternative to bypass or percutaneous stenting in patients with AMI who require abdominal exploration and in those who have flush mesenteric occlusions and have failed to respond to or are considered unsuitable for stenting by a percutaneous approach. Despite high technical success, mortality remains elevated in patients with AMI. Patency rates and freedom from symptom recurrence and reinterventions are comparable to the results achieved with stenting using percutaneous technique.
引用
- Oderich GS, Macedo R, Stone DH, et al. Multicenter study of retrograde open mesenteric artery stenting through laparotomy for treatment of acute and chronic mesenteric ischemia. J Vasc Surg. 2018. PMID: 29548812. doi:10.1016/j.jvs.2017.11.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。